Your browser doesn't support javascript.
loading
Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2-Positive Breast Cancer: Analysis of the NSABP B-31 Trial.
Gavin, Patrick G; Song, Nan; Kim, S Rim; Lipchik, Corey; Johnson, Nicole L; Bandos, Hanna; Finnigan, Melanie; Rastogi, Priya; Fehrenbacher, Louis; Mamounas, Eleftherios P; Swain, Sandra M; Wickerham, D Lawrence; Geyer, Charles E; Jeong, Jong-Hyeon; Costantino, Joseph P; Wolmark, Norman; Paik, Soonmyung; Pogue-Geile, Kay L.
Afiliación
  • Gavin PG; National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania.
  • Song N; National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania.
  • Kim SR; National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania.
  • Lipchik C; National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania.
  • Johnson NL; National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania.
  • Bandos H; Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Finnigan M; National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania.
  • Rastogi P; National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania3University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania.
  • Fehrenbacher L; National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania4Kaiser Permanente, Northern California, Vallejo, California.
  • Mamounas EP; National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania5UF Cancer Center at Orlando Health, Orlando, Florida.
  • Swain SM; National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania6Washington Cancer Institute, Medstar Washington Hospital Center, Washington, DC7Georgetown University Medical Center, Washington, DC.
  • Wickerham DL; National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania8Allegheny Health Network Cancer Institute, Pittsburgh, Pennsylvania.
  • Geyer CE; National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania9Virginia Commonwealth University, Massey Cancer Center, Richmond.
  • Jeong JH; National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania2Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Costantino JP; National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania2Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Wolmark N; National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania8Allegheny Health Network Cancer Institute, Pittsburgh, Pennsylvania.
  • Paik S; National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania10Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, Korea.
  • Pogue-Geile KL; National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania.
JAMA Oncol ; 3(3): 335-341, 2017 Mar 01.
Article en En | MEDLINE | ID: mdl-27812689
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptores de IgG / Trastuzumab / Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: JAMA Oncol Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptores de IgG / Trastuzumab / Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: JAMA Oncol Año: 2017 Tipo del documento: Article